Bristol-Myers Inks Up to $15 Billion Licensing Deal With Hengrui
Bristol-Myers Squibb Co. inked a collaboration and licensing deal with Jiangsu Hengrui Pharmaceuticals Co. that could be valued at as…
Tag: BristolMyers
Analyst Report: Bristol-Myers Squibb Co
Analyst Report: Bristol-Myers Squibb Co finance.yahoo.com #Analyst #Report #BristolMyers #Squibb
DoorDash Drives Higher on a New Partnership; Bristol-Myers Squibb Stock Falls
Chelsea Guglielmino / Getty Images DoorDash was the best-performing stock in the S&P 500 Friday. A delivery company got a…
Bristol-Myers Squibb Company Confirms Efficacy and Safety of Sotyktu for Psoriatic Arthritis and Lupus with New Long-Term Data
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best NYSE stocks to buy and hold for the next decade. On…
Why Bristol-Myers Squibb (BMY) Deserves a Spot in Passive Income Portfolios
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 12 Best Stocks to Buy Now for Passive Income. Why Bristol-Myers Squibb…
Bristol-Myers Squibb Company (BMY) to Divest 60% China JV Amid Strategic Realignment
In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires.…
Analyst Report: Bristol-Myers Squibb Co.
Analyst Report: Bristol-Myers Squibb Co. finance.yahoo.com #Analyst #Report #BristolMyers #Squibb
Why Investors View Bristol‑Myers Squibb (BMY) as a Safe Dividend Stock for Income
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Best and Safe Dividend Stocks to Buy Now. Why Investors View…
Bristol-Myers to Pay $11 Billion to License Cancer Drug
Bristol-Myers Squibb Co. will pay BioNTech SE as much as $11.1 billion to license a next-generation cancer drug, as competition intensifies in an…